A recent investigation attributed 18% of the familial risk of breast cancer risk to SNPs6, although any potential correlation between ANGPT2 gene polymorphisms and malignant breast neoplasms has not been explored so far. This evidence concerns the gene ANGPT2 and breast cancer.